Cargando…

Combined estrogen-progestin pill is a safe and effective option for endometrial hyperplasia without atypia: a three-year single center experience

OBJECTIVE: To evaluate the effectiveness of oral contraceptive pill (OCP) as therapy for endometrial hyperplasia (EH) without atypia in reproductive-aged women compared with oral progestin. METHODS: A retrospective cohort study was carried out in our reproductive center. Consecutive patients diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yang, Nisenblat, Victoria, Tao, Liyuan, Zhang, XinYu, Li, Hongzhen, Ma, Caihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424840/ https://www.ncbi.nlm.nih.gov/pubmed/30887764 http://dx.doi.org/10.3802/jgo.2019.30.e49

Ejemplares similares

Efficacy of Oral Medications or Intrauterine Device-Delivered Progestin in Patients with Endometrial Hyperplasia with or without Atypia: A Network Meta-Analysis
por: Zhang, Yu-Fei, et al.
Publicado: (2023)

Dienogest versus norethisterone acetate in management of endometrial hyperplasia without atypia
por: Girbash, Ehab F., et al.
Publicado: (2023)

The value of MRI in management of endometrial hyperplasia with atypia
por: Natarajan, Purushothaman, et al.
Publicado: (2020)

MicroRNAs as Predictors of Future Uterine Malignancy in Endometrial Hyperplasia without Atypia
por: Lin, Chiao-Yun, et al.
Publicado: (2022)

Comparison of the effectiveness of the levonorgestrel-intrauterine device and oral progestogens on regression of endometrial hyperplasia without atypia
por: Shen, Ye, et al.
Publicado: (2022)

Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma
por: Lv, Mu, et al.
Publicado: (2022)

Prostatic Stromal Hyperplasia with Atypia
por: Hutchinson, Ryan C., et al.
Publicado: (2013)

A Randomized Clinical Trial of Levonorgestrel Intrauterine System with or without Metformin for Treatment of Endometrial Hyperplasia without Atypia in Indian Women
por: Dinnekere Ravi, Ramya, et al.
Publicado: (2021)

Non-atypical endometrial hyperplasia: risk factors for occult endometrial atypia and malignancy in patients managed with hysterectomy
por: Hui, Lee Shi, et al.
Publicado: (2021)

Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis
por: Shao, Fengping, et al.
Publicado: (2023)

Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen
por: Regidor, Pedro-Antonio, et al.
Publicado: (2023)

Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management
por: Nwanodi, Oroma
Publicado: (2017)

Identification of Genes and Pathways Differentially Expressed in Progestin Responsive Endometrial Cancer and Hyperplasia
por: Gertz, Jay, et al.
Publicado: (2021)

Therapeutic options for management of endometrial hyperplasia
por: Chandra, Vishal, et al.
Publicado: (2016)

Patient experiences of conservative treatment for early stage endometrial cancer and endometrial hyperplasia with atypia using levonorgestrel intrauterine device: A qualitative study
por: O'Hara, Montana, et al.
Publicado: (2021)

Modulatory Effect of Fermented Papaya Extracts on Mammary Gland Hyperplasia Induced by Estrogen and Progestin in Female Rats
por: You, Zhenqiang, et al.
Publicado: (2017)

Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients
por: Mitsuhashi, Akira, et al.
Publicado: (2019)

Postmenopausal estrogen and progestin effects on the serum proteome
por: Pitteri, Sharon J, et al.
Publicado: (2009)

Fertility-preserving treatment in complex atypical hyperplasia and early endometrial cancer in young women with oral progestin: Is it effective?
por: Baek, Ji Sun, et al.
Publicado: (2016)

Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone
por: Römer, Thomas, et al.
Publicado: (2021)

Reproductive outcomes in women with unicornuate uterus undergoing in vitro fertilization: a nested case-control retrospective study
por: Chen, Yanrong, et al.
Publicado: (2018)

Correction: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone
por: Römer, Thomas, et al.
Publicado: (2021)

HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
por: Ørbo, Anne, et al.
Publicado: (2016)

HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
por: Ørbo, Anne, et al.
Publicado: (2016)

Estrogen–progestin replacement therapy: regulatory action needed
por: Pike, Malcolm C, et al.
Publicado: (2002)

Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study
por: Kim, Mi Kyoung, et al.
Publicado: (2020)

Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report
por: Liang, Angela L., et al.
Publicado: (2021)

Prominent decidualization following progestin treatment for endometrial hyperplasia and carcinoma as a mimic of large residual tumor: A cautionary tale
por: Hu, Yang, et al.
Publicado: (2021)

Characteristics of progestin-insensitive early stage endometrial cancer and atypical hyperplasia patients receiving second-line fertility-sparing treatment
por: Zhou, Shuang, et al.
Publicado: (2021)

Identification of potential models for predicting progestin insensitivity in patients with endometrial atypical hyperplasia and endometrioid endometrial cancer based on ATAC-Seq and RNA-Seq integrated analysis
por: Hu, Jia-Li, et al.
Publicado: (2022)

Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments
por: Rajkumar, Lakshmanaswamy, et al.
Publicado: (2004)

Estrogens and Progestins Cooperatively Shift Breast Cancer Cell Metabolism
por: Ward, Ashley V., et al.
Publicado: (2022)

Efficacy of Low-Dose Estrogen–Progestins and Progestins in Japanese Women with Dysmenorrhea: A Systematic Review and Network Meta-analysis
por: Iwata, Masaru, et al.
Publicado: (2022)

Response to comment on: Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study
Publicado: (2020)

Letter to editor in response to: Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study
Publicado: (2020)

Effect of Alcohol Ingestion on Carcinogenesis by Synthetic Estrogen and Progestin in the Rat Liver
por: Yamagiwa, Kentaro, et al.
Publicado: (1991)

Is the Expression of the Components of the Carotid Matrix of Rats Influenced by Estrogen, Progestin and Tibolone?
por: Steiner, Marcelo Luis, et al.
Publicado: (2019)

A Very Unusual Thyroid Tumor: a Nodule with Mature Fat Papillary Hyperplasia and Focal Atypia
por: Cacchi, Claudio, et al.
Publicado: (2013)

Prognostic importance of atypical endometriosis with architectural hyperplasia versus cytologic atypia in endometriosis-associated ovarian cancer
por: Ñiguez Sevilla, Isabel, et al.
Publicado: (2019)

Interest in Continued Use After Participation in a Study of Over-the-Counter Progestin-Only Pills in the United States
por: Grindlay, Kate, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dehhhv1fgv5islhh92rtom40oi